The Online Cancer News and Information
In a new study published online Monday in the Journal of Clinical Oncology, researchers report that the rate of double mastectomy in women with single-breast cancer rose 150 percent in six years – even though the aggressive treatment doesn’t necessarily improve survival rates. The researchers used a national cancer-treatment database to study the treatment decisions [...]
{ 0 comments }
Shirley McQueen is a fashion store owner. She lives in terror of something her family calls ‘the beast’. It’s killed 14 of her relatives, but Shirley McQueen has a radical plan to evade the disease. Shirley McQueen has spent most of her life preparing for her death; she has even planned her funeral. “The Beast” [...]
{ 1 comment }
A new study has shown that magnetic resonance imaging scans (MRIs) were more effective at detecting early stages of breast cancer than traditional mammograms. The research, published in the Lancet medical journal, found that 92 per cent of cases of early breast cancer were detected by the MRI scan, whereas only 56 per cent of [...]
{ 0 comments }
High-fat diet may increase breast cancer risk. According to a large study of middle-age women with a wide range of fat in their diet shows that eating a high-fat diet raises the risk of developing invasive breast cancer. This report in the Journal of the National Cancer Institute, stem from the National Institutes of Health-AARP [...]
{ 0 comments }
Researchers in Spain conducted a Phase III clinical trial called GEICAM. They wanted to compare different chemotherapy regimes in women diagnosed with metastatic breast cancer. The trial included 252 women who had already been treated with anthracyclines and taxanes and experienced a recurrence.One group of women was treated with Gemzar (gemcitabine) and Navelbine (vinorelbine), the [...]
{ 0 comments }
The new drug exemestane for breast cancer treatment could improve survival rates by 17 percent, new research shows. A study of 4,742 post-menopausal women found that switching from the present gold-standard breast cancer treatment tamoxifen to the new drug exemestane after two or three years resulted in a dramatic fall in death rates, The Times [...]
{ Comments on this entry are closed }
Agendia has announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s MammaPrint(C) breast cancer diagnostic test. MammaPrint® is a gene expression profiling service to assess the risk of recurrence in breast cancer patients. The US Food and Drug Administration has approved MammaPrint, a new genetic test that can help predict whether [...]
{ Comments on this entry are closed }
Results published at the annual San Antonio Breast Cancer Symposium, said that Abraxane in combination with Xeloda may be an effective treatment option for patients with metastatic breast cancer.Abraxane is a newer form of Taxol that uses albumin, a natural protein found in the body, to deliver high concentrations of the active ingredient into the [...]
{ 0 comments }
Touch imprint cytology (TIC) lymph node assessment during breast cancer surgery could prove to have advantages over the current standard lymph node assessment. TIC can be important to the breast cancer patient because usually the results from the lymph node dissection can take up to a week. It causes a lot of anxiety and stress [...]
{ 0 comments }
A synthetic steroid compound used to abort pregnancy could fight breast and ovarian cancer, caused by a mutant gene, from growing, according to researchers at the UniversityCalifornia, Irvine. The research published in the December 1 issue of journal Science, revealed that by blocking the hormone progesterone in breast tissue cells, the drug can also prevent [...]
{ 0 comments }
North Carolina State Director of Athletics Lee Fowler and Head Women’s Basketball Coach Kay Yow announced jointly that Yow will be taking a leave of absence from her coaching duties for an indefinite period of time. Associate head coach Stephanie Glance will serve as interim coach, Yow and athletic director Lee Fowler said in a [...]
{ 0 comments }
In September of 1998, the FDA approved Herceptin to treat breast cancer after it had become metastatic. Few days back, the FDA approved Herceptin’s use for women diagnosed with breast cancer just after surgery. The drug is already widely prescribed for adjuvant therapy even without the FDA’s approval, a practice called off-label use. Off-label use [...]
{ 0 comments }
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||